Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Gains from Investment Securities (2016 - 2025)

CorMedix has reported Gains from Investment Securities over the past 13 years, most recently at $2.0 million for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $2.0 million for Q4 2025, up 626.83% from a year ago — trailing twelve months through Dec 2025 was -$41.1 million (down 19.84% YoY), and the annual figure for FY2025 was $1.7 million, down 20.44%.
  • Gains from Investment Securities reached $2.0 million in Q4 2025 per CRMD's latest filing, down from $2.1 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $8.8 million in Q4 2022 and bottomed at -$42.7 million in Q3 2023.
  • Median Gains from Investment Securities over the past 5 years was $1.5 million (2021), compared with a mean of -$5674.0.
  • The largest annual shift saw Gains from Investment Securities surged 4725.35% in 2021 before it plummeted 37361600.0% in 2024.
  • Over 5 years, Gains from Investment Securities stood at $6.5 million in 2021, then surged by 34.96% to $8.8 million in 2022, then tumbled by 100.0% to $1.0 in 2023, then tumbled by 37361600.0% to -$373615.0 in 2024, then skyrocketed by 626.83% to $2.0 million in 2025.
  • Business Quant data shows Gains from Investment Securities for CRMD at $2.0 million in Q4 2025, $2.1 million in Q3 2025, and $1.9 million in Q2 2025.